Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decay acceleration of the complement alternative pathway C3 convertase.

D E Hourcade1, L M Mitchell, M E Medof

  • 1Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA. dhourcad@im.wustl.edu

Immunopharmacology
|July 17, 1999
PubMed
Summary

Human decay-accelerating factor (DAF) and factor H accelerate complement C3 convertase decay on mature complexes but not precursors. This clarifies how these regulators control the complement system for potential therapeutic applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anatomic and neuromuscular characterisation of the equine cricothyroid muscle.

Equine veterinary journal·2013
Same author

Distinct responses of splenic dendritic cell subsets to infection with Listeria monocytogenes: maturation phenotype, level of infection, and T cell priming capacity ex vivo.

Cellular immunology·2011
Same author

Incidence of swallowing during exercise in horses with dorsal displacement of the soft palate.

Equine veterinary journal·2010
Same author

Considerations for pacing of the cricoarytenoid dorsalis muscle by neuroprosthesis in horses.

Equine veterinary journal·2010
Same author

Successful treatment of persistent dorsal displacement of the soft palate and evaluation of laryngohyoid position in 15 racehorses.

Equine veterinary journal·2010
Same author

Decay accelerating factor is essential for successful corneal engraftment.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2010

Area of Science:

  • Immunology
  • Biochemistry

Background:

  • The alternative pathway of the complement system is crucial for immune responses.
  • C3 convertases are key enzymes in this pathway, responsible for cleaving C3.
  • Dysregulation of the complement system is implicated in various diseases.

Purpose of the Study:

  • To elucidate the mechanism by which C3 regulatory proteins accelerate the decay of the alternative pathway C3 convertase.
  • To investigate the activity of human decay-accelerating factor (DAF) and factor H on different stages of convertase complex formation.

Main Methods:

  • Development and application of an ELISA-based assay.
  • Analysis of the activity of DAF and factor H on nascent (C3bB) and mature (C3bBb) C3 convertase complexes.

Main Results:

Related Experiment Videos

  • DAF and factor H were found to be active on mature C3bBb convertase complexes.
  • These regulators showed no activity on the nascent C3bB precursor complex.
  • This indicates a stage-specific mechanism of action for these complement regulators.

Conclusions:

  • The findings provide novel insights into the distinct mechanisms of action of DAF and factor H.
  • Understanding these regulatory mechanisms is essential for developing therapeutic strategies targeting the complement system.
  • This research contributes to the biochemical understanding of complement regulation and its therapeutic implications.